CN103113594B - 琼脂糖-聚乙烯亚胺-透明质酸接枝物及其制备方法与应用 - Google Patents
琼脂糖-聚乙烯亚胺-透明质酸接枝物及其制备方法与应用 Download PDFInfo
- Publication number
- CN103113594B CN103113594B CN201310030896.3A CN201310030896A CN103113594B CN 103113594 B CN103113594 B CN 103113594B CN 201310030896 A CN201310030896 A CN 201310030896A CN 103113594 B CN103113594 B CN 103113594B
- Authority
- CN
- China
- Prior art keywords
- agarose
- polymine
- hyaluronic acid
- preparation
- degraded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920002674 hyaluronan Polymers 0.000 title claims abstract description 45
- 229960003160 hyaluronic acid Drugs 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 229920000936 Agarose Polymers 0.000 claims abstract description 77
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 20
- 239000000243 solution Substances 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- 238000001556 precipitation Methods 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 27
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 26
- 229910052757 nitrogen Inorganic materials 0.000 claims description 26
- 229920002873 Polyethylenimine Polymers 0.000 claims description 24
- 238000006243 chemical reaction Methods 0.000 claims description 24
- 238000000502 dialysis Methods 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 14
- 230000000593 degrading effect Effects 0.000 claims description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 12
- 229920002684 Sepharose Polymers 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 12
- 229960004756 ethanol Drugs 0.000 claims description 10
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 8
- 238000012869 ethanol precipitation Methods 0.000 claims description 6
- 239000005457 ice water Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 11
- 239000000463 material Substances 0.000 abstract description 10
- 229940079593 drug Drugs 0.000 abstract description 6
- 108090000623 proteins and genes Proteins 0.000 abstract description 6
- 230000008685 targeting Effects 0.000 abstract description 5
- 239000003937 drug carrier Substances 0.000 abstract description 4
- 229920000642 polymer Polymers 0.000 abstract description 4
- 239000012876 carrier material Substances 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- 239000011859 microparticle Substances 0.000 abstract description 2
- 238000006065 biodegradation reaction Methods 0.000 abstract 1
- 150000001718 carbodiimides Chemical class 0.000 abstract 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 238000002329 infrared spectrum Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 238000013270 controlled release Methods 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 239000003519 biomedical and dental material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002861 polymer material Substances 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 229920001897 terpolymer Polymers 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010072170 Skin wound Diseases 0.000 description 2
- 108020004459 Small interfering RNA Proteins 0.000 description 2
- 230000008614 cellular interaction Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- -1 carbon diimine amine Chemical class 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229910000071 diazene Inorganic materials 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000012637 gene transfection Methods 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 231100000652 hormesis Toxicity 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000011580 nude mouse model Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 229920001601 polyetherimide Polymers 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310030896.3A CN103113594B (zh) | 2013-01-25 | 2013-01-25 | 琼脂糖-聚乙烯亚胺-透明质酸接枝物及其制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310030896.3A CN103113594B (zh) | 2013-01-25 | 2013-01-25 | 琼脂糖-聚乙烯亚胺-透明质酸接枝物及其制备方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103113594A CN103113594A (zh) | 2013-05-22 |
CN103113594B true CN103113594B (zh) | 2014-12-31 |
Family
ID=48412018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310030896.3A Active CN103113594B (zh) | 2013-01-25 | 2013-01-25 | 琼脂糖-聚乙烯亚胺-透明质酸接枝物及其制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103113594B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107406523B (zh) | 2015-03-20 | 2020-09-22 | 杨达志 | 多糖-聚氨共聚物及其在降低血浆中尿酸浓度的应用 |
CN109364256B (zh) * | 2018-11-13 | 2021-07-27 | 广西科学院 | 一种琼脂糖胶束药物载体 |
CN109880108B (zh) * | 2019-03-06 | 2020-12-22 | 武汉轻工大学 | 一种聚乙烯亚胺接枝米糠多糖铁的制备方法及基因载体 |
CN110218342A (zh) * | 2019-05-13 | 2019-09-10 | 暨南大学 | 琼脂糖-明胶接枝物温敏水凝胶及其制备方法与应用 |
CN112169013B (zh) * | 2019-07-05 | 2022-07-29 | 香港城市大学 | 一种粒子堆垛型生物胶黏剂及其制备与应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060149392A1 (en) * | 2004-12-07 | 2006-07-06 | Kuo-Huang Hsieh | Biomaterials for guided tissue regeneration and drug delivery |
CN101134784B (zh) * | 2007-08-16 | 2010-06-16 | 暨南大学 | 琼脂糖与透明质酸接枝物及其制备方法与应用 |
CN102408498A (zh) * | 2011-09-16 | 2012-04-11 | 大连大学 | 一种透明质酸键合聚乙烯亚胺共聚物、其制备方法及应用 |
-
2013
- 2013-01-25 CN CN201310030896.3A patent/CN103113594B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103113594A (zh) | 2013-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Preparation of alginate-based biomaterials and their applications in biomedicine | |
Xu et al. | Poly (N-isopropylacrylamide)-based thermoresponsive composite hydrogels for biomedical applications | |
CN103113594B (zh) | 琼脂糖-聚乙烯亚胺-透明质酸接枝物及其制备方法与应用 | |
Wang et al. | Functional hydrogels and their application in drug delivery, biosensors, and tissue engineering | |
Kalirajan et al. | A critical review on polymeric biomaterials for biomedical applications | |
Savina et al. | Design and assessment of biodegradable macroporous cryogels as advanced tissue engineering and drug carrying materials | |
Raftery et al. | Chitosan for gene delivery and orthopedic tissue engineering applications | |
Wang et al. | Chitosan-based injectable hydrogels for biomedical applications | |
Goodarzi et al. | Injectable drug loaded gelatin based scaffolds as minimally invasive approach for drug delivery system: CNC/PAMAM nanoparticles | |
Lynch et al. | Advanced strategies for tissue engineering in regenerative medicine: A biofabrication and biopolymer perspective | |
Nguyen et al. | Tetronic-grafted chitosan hydrogel as an injectable and biocompatible scaffold for biomedical applications | |
Bao et al. | The influence of solvent formulations on thermosensitive hydroxybutyl chitosan hydrogel as a potential delivery matrix for cell therapy | |
CN101134784B (zh) | 琼脂糖与透明质酸接枝物及其制备方法与应用 | |
Chen et al. | Bone regeneration using MMP-cleavable peptides-based hydrogels | |
CN113633821A (zh) | 一种温敏型可注射型胶原/壳聚糖/掺锌生物玻璃纳米颗粒水凝胶材料及其制备方法 | |
CN109627463B (zh) | 水凝胶与蛋白质药物 | |
Tian et al. | Preparation and characterization of galactosylated alginate–chitosan oligomer microcapsule for hepatocytes microencapsulation | |
CN105524272A (zh) | 硫辛酸修饰的聚乙二醇-聚氨基酸嵌段共聚物的制备和应用 | |
KR20110076838A (ko) | 수화겔, 이의 제조 방법 및 용도 | |
Wartenberg et al. | Glycosaminoglycan-based cryogels as scaffolds for cell cultivation and tissue regeneration | |
Zhao et al. | Natural polymer-based hydrogels: From polymer to biomedical applications | |
CN102309760A (zh) | 一种阳离子型两亲性壳聚糖纳米药物载体及其制备和应用 | |
Chen et al. | Structure and properties of gelatin methacryloyl (GelMA) synthesized in different reaction systems | |
Patil et al. | Alginate/poly (amidoamine) injectable hybrid hydrogel for cell delivery | |
MohanKumar et al. | Hydrogels: potential aid in tissue engineering—a review |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160913 Address after: 510530 Guangdong city of Guangzhou province Luogang District jade Yan Road No. 12 Patentee after: GUANGZHOU YUEQING REGENERATION MEDICINE TECHNOLOGY Co.,Ltd. Address before: 510632 Whampoa West Road, Guangdong, Guangzhou, No. 601, No. Patentee before: Jinan University |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Agarose polyethyleneimine hyaluronic acid graft copolymer and its preparation method and application Effective date of registration: 20231212 Granted publication date: 20141231 Pledgee: CITIC Bank Co.,Ltd. Guangzhou Branch Pledgor: GUANGZHOU YUEQING REGENERATION MEDICINE TECHNOLOGY Co.,Ltd. Registration number: Y2023980070512 |